Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 3
2007 1
2008 4
2009 1
2010 3
2011 4
2012 4
2013 4
2014 6
2015 4
2016 6
2017 7
2018 3
2019 2
2020 7
2021 5
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models.
Guerrieri AN, Bellotti C, Penzo M, Columbaro M, Pannella M, De Vita A, Gambarotti M, Mercatali L, Laranga R, Dozza B, Vanni S, Corsini S, Frisoni T, Miserocchi G, Ibrahim T, Lucarelli E. Guerrieri AN, et al. Among authors: lucarelli e. BMC Cancer. 2023 Dec 6;23(1):1194. doi: 10.1186/s12885-023-11658-9. BMC Cancer. 2023. PMID: 38057796 Free PMC article.
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Lucarelli E, De Vita A, Bellotti C, Frisoni T, Vanni S, Guerrieri AN, Pannella M, Mercatali L, Gambarotti M, Duchi S, Miserocchi G, Maioli M, Liverani C, Ibrahim T. Lucarelli E, et al. Cancers (Basel). 2023 Oct 25;15(21):5132. doi: 10.3390/cancers15215132. Cancers (Basel). 2023. PMID: 37958307 Free PMC article. Review.
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. Mercatali L, et al. Among authors: lucarelli e. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324885 Free PMC article. Review.
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
Vanni S, De Vita A, Gurrieri L, Fausti V, Miserocchi G, Spadazzi C, Liverani C, Cocchi C, Calabrese C, Bongiovanni A, Riva N, Mercatali L, Pieri F, Casadei R, Lucarelli E, Ibrahim T. Vanni S, et al. Among authors: lucarelli e. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221093973. doi: 10.1177/17588359221093973. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35782752 Free PMC article. Review.
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model.
Martella E, Dozza B, Ferroni C, Obeyok CO, Guerrini A, Tedesco D, Manet I, Sotgiu G, Columbaro M, Ballestri M, Martini L, Fini M, Lucarelli E, Varchi G, Duchi S. Martella E, et al. Among authors: lucarelli e. Pharmaceutics. 2022 Mar 19;14(3):677. doi: 10.3390/pharmaceutics14030677. Pharmaceutics. 2022. PMID: 35336051 Free PMC article.
71 results